Screener
ADMA Biologics ADMA Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's interest expense?
- ADMA Biologics (ADMA) reported interest expense of $3.42M in Q2 2026.
- How has ADMA Biologics's interest expense changed year-over-year?
- ADMA Biologics's interest expense increased by 86.7% year-over-year, from $1.83M to $3.42M.
- What is the long-term trend for ADMA Biologics's interest expense?
- Over 4 years (2021 to 2025), ADMA Biologics's interest expense has grown at a -14.1% compound annual growth rate (CAGR), from $13.06M to $7.11M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about ADMA Biologics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude